Ypsomed Holding AG (SW:YPSN) — Market Cap & Net Worth
Market Cap & Net Worth: Ypsomed Holding AG (YPSN)
Ypsomed Holding AG (SW:YPSN) has a market capitalization of $3.85 Billion (CHF3.04 Billion) as of May 2, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #4249 globally and #62 in its home market, demonstrating a -4.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ypsomed Holding AG's stock price CHF273.00 by its total outstanding shares 13645773 (13.65 Million). Analyse Ypsomed Holding AG operating cash flow efficiency to see how efficiently the company converts income to cash.
Ypsomed Holding AG Market Cap History: 2015 to 2026
Ypsomed Holding AG's market capitalization history from 2015 to 2026. Data shows growth from $2.40 Billion to $4.71 Billion (9.23% CAGR).
Ypsomed Holding AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ypsomed Holding AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.56x
Ypsomed Holding AG's market cap is 7.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
64.67x
Ypsomed Holding AG's market cap is 64.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.08 Billion | $336.92 Million | $35.81 Million | 9.15x | 86.05x |
| 2017 | $2.69 Billion | $389.56 Million | $46.25 Million | 6.91x | 58.23x |
| 2018 | $1.96 Billion | $466.12 Million | $52.06 Million | 4.21x | 37.72x |
| 2019 | $2.23 Billion | $453.76 Million | $60.14 Million | 4.91x | 37.03x |
| 2020 | $2.52 Billion | $394.26 Million | $11.73 Million | 6.39x | 214.84x |
| 2021 | $3.18 Billion | $403.66 Million | $5.81 Million | 7.89x | 547.78x |
| 2022 | $2.90 Billion | $464.84 Million | $23.11 Million | 6.23x | 125.42x |
| 2023 | $5.21 Billion | $497.46 Million | $51.27 Million | 10.48x | 101.69x |
| 2024 | $5.65 Billion | $548.46 Million | $78.37 Million | 10.30x | 72.10x |
| 2025 | $5.66 Billion | $748.87 Million | $87.50 Million | 7.56x | 64.67x |
Competitor Companies of YPSN by Market Capitalization
Companies near Ypsomed Holding AG in the global market cap rankings as of May 2, 2026.
Key companies related to Ypsomed Holding AG by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Ypsomed Holding AG Historical Marketcap From 2015 to 2026
Between 2015 and today, Ypsomed Holding AG's market cap moved from $2.40 Billion to $ 4.71 Billion, with a yearly change of 9.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF4.71 Billion | -16.77% |
| 2025 | CHF5.66 Billion | +0.15% |
| 2024 | CHF5.65 Billion | +8.35% |
| 2023 | CHF5.21 Billion | +79.94% |
| 2022 | CHF2.90 Billion | -8.96% |
| 2021 | CHF3.18 Billion | +26.27% |
| 2020 | CHF2.52 Billion | +13.21% |
| 2019 | CHF2.23 Billion | +13.38% |
| 2018 | CHF1.96 Billion | -27.07% |
| 2017 | CHF2.69 Billion | -12.61% |
| 2016 | CHF3.08 Billion | +28.37% |
| 2015 | CHF2.40 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Ypsomed Holding AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.85 Billion USD |
| MoneyControl | $3.85 Billion USD |
| MarketWatch | $3.85 Billion USD |
| marketcap.company | $3.85 Billion USD |
| Reuters | $3.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more